Mario Fernández-Ruiz

TL;DR: Patients with BSIs due to CPE should receive active therapy as soon as they are diagnosed, and monotherapy should be considered for those in the low-mortality-score stratum.

TL;DR: It is suggested that SARS‐CoV‐2 infection has a severe course in SOT recipients, and c‐reactive protein levels at various points were significantly higher among recipients who experienced unfavorable outcome.

TL;DR: The findings provide comprehensive information about characteristics and complications of severe COVID-19 and may help to identify patients at a higher risk of death.

TL;DR: In the absence of an apparent predictor of the development of disseminated BCG infection after intravesical therapy, and considering the protean variety of clinical manifestations, it is essential to keep a high index of suspicion to initiate adequate therapy promptly and to evaluate carefully the risk-benefit balance of resuming intravesicals BCG immunotherapy.

TL;DR: A personal viewpoint representing different jurisdictions from around the world in order to outline the impact of the current COVID‐19 pandemic on organ transplantation and issues related to transplant‐related research during the pandemic are discussed.